Nestle and krill oil
This article was originally published in The Tan Sheet
Executive Summary
Neptune Technologies & Bioressources and Nestle Research Center agree to conduct joint research on the effects of Neptune Krill Oil on "exceptionally prevalent conditions affecting the worldwide adult population," Neptune announces July 12. The firms began research at the beginning of July and have determined the study design and the trial's primary investigators. The companies will proceed with a development and license agreement upon successful completion of the trial, according to Neptune...
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.